Structure-activity relationships of dopamine agonists.
D000818:Animals; D001060:Aporphines / Q000494:pharmacology; D001552:Benzazepines / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology*; D004876:Ergot Alkaloids / Q000494:pharmacology*; D007189:Indans / Q000494:pharmacology*; D007192:Indenes / Q000494:pharmacology*; D009281:Naphthalenes / Q000494:pharmacology*; D010627:Phenethylamines / Q000494:pharmacology*; D011804:Quinolines / Q000494:pharmacology; D011954:Receptors, Dopamine / Q000187:drug effects; D013329:Structure-Activity Relationship; D013764:Tetrahydronaphthalenes / Q000494:pharmacology*
D001060:Aporphines; D001552:Benzazepines; D004876:Ergot Alkaloids; D007189:Indans; D007192:Indenes; D009281:Naphthalenes; D010627:Phenethylamines; D011804:Quinolines; D011954:Receptors, Dopamine; D013764:Tetrahydronaphthalenes; D004298:Dopamine